Clinical Trial and Error?

It’s about time for a clinical trial revolution. For decades, patient recruitment and retention have been plagued by systemic inefficiencies, leaving countless patients unheard and potentially life-saving treatments unexplored. The stark reality is that our current methods are not just outdated–they’re actively hindering progress. In fact, 9 of 10 trials ultimately double their original timeline in order to meet enrollment goals and 11% of research sites fail to enroll even a single patient. AI and emerging technologies are poised to shatter these longstanding barriers, offering a glimpse into a future where trials can be more effective. We’re seeing AI algorithms that can match patients to trials with precision, decentralized processes that bring studies to the participant rather than the other way around, and community partnerships that are built on trust. These advancements should be paired with the imperative to serve populations safely, equitably, and ethically. Let's dissect the current state of clinical trials, expose the gaps that have held us back, and chart a course toward a more inclusive, efficient future. This isn't just a discussion—it's a call to action.